RISING BIOSCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.001 USD | +11.11% |
|
+400.00% | -16.67% |
| 2021 | Rising BioSciences, Inc. acquired OXY THYME Southeast, Inc. | CI |
| 2019 | Rising BioSciences, Inc. acquired Southern Northern Behavioral Health, Inc. | CI |
More news
| 1 day | +11.11% |
| Managers | Title | Age | Since |
|---|---|---|---|
Arthur Hall
CEO | Chief Executive Officer | - | - |
Jim DiPrima
DFI | Director of Finance/CFO | 75 | - |
| Chief Operating Officer | - | 19-03-07 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jim DiPrima
DFI | Director of Finance/CFO | 75 | - |
Arthur Hall
CEO | Chief Executive Officer | - | - |
Rising Biosciences, Inc. is a research and development company. The Company is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The Company operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physicianâs practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.
Sector
Entertainment Production
| 1st Jan change | Capi. | |
|---|---|---|
| +11.74% | 7.96B | |
| +10.09% | 5.84B | |
| -8.57% | 5.8B | |
| +2.84% | 4.49B | |
| +8.88% | 4.17B | |
| +13.50% | 3.62B | |
| -1.63% | 3.03B | |
| +7.51% | 2.65B | |
| +36.29% | 1.85B |
- Stock Market
- Equities
- RBII Stock
- RBII Stock
